Literature DB >> 27117985

Radionecrosis versus disease progression in brain metastasis. Value of (18)F-DOPA PET/CT/MRI.

J Hernández Pinzón1, D Mena2, M Aguilar3, F Biafore4, G Recondo5, M Bastianello6.   

Abstract

The use of (18)F-DOPA PET/CT with magnetic resonance imaging fusion and the use of visual methods and quantitative analysis helps to differentiate between changes post-radiosurgery vs. suspicion of disease progression in a patient with brain metastases from melanoma, thus facilitating taking early surgical action.
Copyright © 2016 Elsevier España, S.L.U. y SEMNIM. All rights reserved.

Entities:  

Keywords:  3,4-dihidroxi-6-(18)F-fluoro-L-fenilalanina, Tomografía por Emisión de Positrones; Fluorine-18L-3, 4 hydroxyphenylalanine, Positron Emission Tomography; Magnetic Resonance Imaging; Melanoma; Metastasis; Metástasis; Radiation Necrosis; Radionecrosis; Resonancia magnética

Mesh：

Substances：

Year:  2016        PMID： 27117985     DOI： 10.1016/j.remn.2016.03.002

Source DB:  PubMed          Journal:  Rev Esp Med Nucl Imagen Mol        ISSN： 2253-654X            Impact factor:   1.359


  2 in total

1.  Local recurrence and cerebral progression-free survival after multiple sessions of stereotactic radiotherapy of brain metastases: a retrospective study of 184 patients : Statistical analysis.

Authors:  Laure Kuntz; Clara Le Fèvre; Delphine Jarnet; Audrey Keller; Philippe Meyer; Caroline Bund; Isabelle Chambrelant; Delphine Antoni; Georges Noel
Journal:  Strahlenther Onkol       Date:  2022-03-16       Impact factor: 4.033

2.  18F-FDOPA-PET in pseudotumoral brain lesions.

Authors:  Dimitri Renard; Laurent Collombier; Sabine Laurent-Chabalier; Thibault Mura; Anne Le Floch; Hassan El Fertit; Eric Thouvenot; Jean Sebastien Guillamo
Journal:  J Neurol       Date:  2020-10-21       Impact factor: 4.849
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.